Isomorphic Labs
subsidiary of Alphabet Inc
Positive
Negative
Entity sentiment
Reports
News
Opinions
Statements
Articles
Relations
science Jan 23, 2026, 1:00 AM
Demis Hassabis aims to solve diseases with advanced AI systems - Demis Hassabis founded Isomorphic Labs in 2021 to explore chemical space with AI.
- The organization aims to create a systematic and scalable drug discovery process.
- Isomorphic Labs has not yet entered any drugs into clinical trials, emphasizing the need for a proven discovery methodology.
100
2026 All rights reserved
2026 All rights reserved